Clinical Trial Update: DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial evaluating validated urine DNA methylation biomarkers for prostate cancer (prostate adenocarcinoma); the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Adenocarcinoma, Prostate Carcinoma | Status: TERMINATED